PAY:NYSEPaymentus Holdings, Inc. Analysis
Data as of 2026-04-23 - not real-time
$27.11
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Paymentus Holdings (PAY) is trading below its long‑term moving average while staying above short‑term averages, indicating a neutral‑to‑bullish technical stance. The MACD histogram is positive and the RSI sits in the mid‑range, suggesting limited downside momentum and room for upside. Fundamentally, the company delivers robust revenue growth and a solid cash position, yet its valuation multiples are elevated relative to peers, though a discounted cash‑flow model points to a meaningful upside potential. Recent material news includes the upcoming first‑quarter earnings release, a sizable RSU grant to the CEO, and the departure of the general counsel, all of which could add short‑term volatility.
Overall, the blend of positive technical signals, strong growth fundamentals, and an implied valuation gap supports a cautiously optimistic outlook, with the primary catalysts being earnings momentum and continued adoption of its cloud‑based payment platform.
Overall, the blend of positive technical signals, strong growth fundamentals, and an implied valuation gap supports a cautiously optimistic outlook, with the primary catalysts being earnings momentum and continued adoption of its cloud‑based payment platform.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Positive MACD and neutral RSI indicating limited downside
- Upcoming earnings report could unlock upside
- Current price positioned between short‑term support and long‑term resistance
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained double‑digit revenue growth
- Strong cash generation and low leverage
- Analyst consensus of buy and implied upside from valuation models
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Long‑term secular shift toward digital and cloud‑based payment solutions
- Stable operating margins with potential for improvement
- Undervalued relative to discounted cash‑flow fair value despite high PE
Key Metrics & Analysis
Financial Health
Revenue Growth28.10%
Profit Margin5.59%
P/E Ratio52.1
ROE12.80%
ROA7.59%
Debt/Equity1.22
P/B Ratio6.1
Op. Cash Flow$162.1M
Free Cash Flow$112.8M
Industry P/E37.0
Technical Analysis
TrendNeutral
RSI54.7
Support$24.07
Resistance$29.77
MA 20$26.15
MA 50$25.32
MA 200$30.37
MACDBullish
VolumeStable
Fear & Greed Index86.34
Valuation
Fair Value$35.78
Target Price$32.29
Upside/Downside19.11%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta1.00
Volatility41.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.